Literature DB >> 26952155

In Response: Dexmedetomidine versus propofol in dilatation and curettage: An open-label pilot randomized controlled trial.

G S Tomar1.   

Abstract

Entities:  

Year:  2016        PMID: 26952155      PMCID: PMC4760033          DOI: 10.4103/1658-354X.169493

Source DB:  PubMed          Journal:  Saudi J Anaesth


× No keyword cloud information.
Sir, We read with interest article by Sethi et al.,[1] in June, 2015 issue of Saudi Journal of Anesthesia. Authors compared patient's and surgeon's satisfaction score and hemodynamics after D and C procedure by using dexmedetomidine infusion and propofol boluses among patients. We have few queries related to their mentioned statement in methodology and discussion part. Authors did not measure any type of parameter for analgesia provided in both the groups and still were able to measure patient's and surgeon's satisfaction score. Moreover, the foremost thing to be asked by anesthetist or surgeon from the patient after any surgical or invasive procedure is about the satisfaction in terms of pain control/analgesia. Did the authors have any rescue analgesia strategy in their methodology? We didn’t find any but of rescue sedation. However, in discussion section authors stated that “Group D had higher satisfaction scores both for patients and surgeon. As propofol sedation in this study was associated with lower patient satisfaction and more use of rescue analgesic.[1]” In contrast with an recently published similar (to some extent) study.[2]
  2 in total

1.  Is dexmedetomidine better than propofol and fentanyl combination in minor day care procedures? A prospective randomised double-blind study.

Authors:  Gaurav Singh Tomar; Farhat Singh; S Ganguly; Neeraj Gaur
Journal:  Indian J Anaesth       Date:  2015-06

2.  Dexmedetomidine versus propofol in dilatation and curettage: An open-label pilot randomized controlled trial.

Authors:  Priyanka Sethi; Sunil Sindhi; Ankita Verma; K L Tulsiani
Journal:  Saudi J Anaesth       Date:  2015 Jul-Sep
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.